Related Experiment Video
Updated: Oct 6, 2025

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
Published on: July 21, 2015
Determinants of mortality and long-term outcome in children with refractory and super refractory status epilepticus
Sita Jayalakshmi1, Anuja Patil1, Anusha Challa1
1Department of Neurology, Krishna Institute of Medical Sciences, Secunderabad, India.
Insights
Progression to super refractory status epilepticus (SRSE) in children with refractory status epilepticus (RSE) did not increase mortality but was linked to poorer outcomes. Over 60% of children experienced good long-term recovery.
Area of Science:
- Pediatric Neurology
- Critical Care Medicine
- Epileptology
Background:
- Refractory status epilepticus (RSE) is a neurological emergency in children.
- Progression to super refractory status epilepticus (SRSE) represents a more severe form of RSE.
- Understanding factors influencing progression and outcomes is crucial for clinical management.
Purpose of the Study:
- To identify factors associated with the progression of convulsive RSE to SRSE in children.
- To evaluate the long-term outcomes of children with RSE and SRSE.
Main Methods:
- Retrospective analysis of data from children admitted with convulsive RSE between 2010 and 2018.
- Outcome assessment at two years using the Glasgow Outcome Scale (GOS).
Main Results:
- Of 56 children, 24 progressed to SRSE. Acute symptomatic etiology was common in both RSE and SRSE groups.
- Children progressing to SRSE had a significantly longer NICU stay (25.2 vs. 4.8 days).
- Progression to SRSE was associated with poorer GOS outcomes (63.6% vs. 29.4%), but mortality rates were similar between RSE and SRSE groups.
Conclusions:
- Acute symptomatic etiology is frequent in pediatric RSE and SRSE.
- Progression to SRSE in children is linked to worse long-term neurological outcomes, not increased mortality.
- A majority of children (60.7%) achieved a good outcome at follow-up.
Aim:
To evaluate factors associated with progression of convulsive refractory status epilepticus(RSE) to super refractory status epilepticus(SRSE) and long term outcome in children.
Materials And Methods:
In this open cohort study, data of children admitted with convulsive RSE from 2010 to 2018 was retrospectively analyzed. The outcome at two years was graded according to the Glasgow outcome scale(GOS).
Results:
Fifty six children formed study population, 24 progressed to SRSE. The mean age of the study population was 9.38 ± 4.28(2-16) years. There was no significant difference for age between SRSE and RSE children (9.53 ± 4.50 years vs. 9.17 ± 4.06 years; p = 0.756). Acute symptomatic aetiology was the most common aetiology for RSE (57.1%) and SRSE (54.2%). There were no differences for aetiology between children who progressed to SRSE and those who did not. Mean length of stay in the NICU was 13.54 ± 17.53 days and children who progressed to SRSE had a longer length of stay in NICU (4.78 ± 3.03 days vs. 25.21 ± 21.77 days; p < 0.001). The mortality was 14.2%. Acidosis was more common in children who died (27.1% vs. 87.5%;p < 0.001). There was no significant difference in the mortality between RSE and SRSE (9.4% vs. 20.8%; p = 0.268). At latest follow up 34 (60.7%) children had good outcome. Poor outcome was more common in children who progressed to SRSE(29.4% vs. 63.6%;p < 0.015).
Conclusion:
Acute symptomatic etiology is more frequent in children with RSE and SRSE. Progression to SRSE did not significantly increase mortality but associated with poor GOS outcome. Encouragingly, 60% of children had good outcome.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism